Dallas children's hospital relocates patients after finding mold

Children's Medical Center Dallas relocated 28 patients after routine air tests


Children's Medical Center Dallas recently relocated 28 patients after routine air tests showed higher-than-normal levels of Aspergillus and Penicillium molds, according to an article on the CNN website.

The patients were moved from the cardiac intensive care unit at Children's Medical Center Dallas to other parts of the facility.

No patients have become infected and none have experienced any health effects as a result of the mold, the hospital said.

No previous tests at the hospital showed mold outside the expected ranges, according to a spokesperson. There is an ongoing investigation into last week's test results.

Read the article.



December 17, 2019


Topic Area: Infection Control


Recent Posts

Dirty Floors: How Pathogens Can Accumulate and Spread Underfoot

Studies show that healthcare floors are covered in bacteria and can quickly spread throughout patient rooms. 


WellSpan Health Opens Its Newberry Hospital in Pennsylvania

This marks the opening of its 10th hospital in the region spanning Central Pennsylvania and Northern Maryland.


Cahaba Center for Mental Health Ensnared in Data Breach

On March 28, 2025, Cahaba identified suspicious activity in an employee email account.


Reframing the Construction Manager as a Community Manager

Managers must work with patients, community residents and other interested parties to ensure a smooth, successful construction projects


Health First Celebrates 'Topping Off' Ceremony for New Cape Canaveral Hospital Campus

Construction is slated to finish by the end of 2026 or early 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.